Administration of a Supratherapeutic Dose of Doravirine Does not Result in a Clinically Meaningful Increase in QTc

Conference Reports for NATAP

16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC


Administration of a Supratherapeutic Dose of Doravirine Does not Result in a Clinically Meaningful Increase in QTc

	Administration of a Supratherapeutic Dose of Doravirine Does not Result in a Clinically Meaningful Increase in QTc